Sullivan Christopher Ryan insider trades
Sullivan Christopher Ryan has filed 21 Form 4s with the SEC that we hold, all for Avalo Therapeutics, Inc. (AVTX), as Chief Financial Officer. Across all of them we count 2 purchases worth $3.2K and 17 sales worth $3.7M reported on Form 4. In the last 12 months: 0 purchases ($0) and 17 sales ($3.7M). The largest single trade was a sale of 37,945 shares of Avalo Therapeutics, Inc. worth $753.3K, dated 2026-08-17. Of 2 sales filed since we began reading the 10b5-1 checkbox, 2 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-12-14 and the latest 2026-09-18.
Avalo Therapeutics, Inc. (AVTX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-12-10 | P, purchase reported on Form 4 | 955 | $1.5K | 2021-12-14 |
| 2023-06-09 | P, purchase reported on Form 4 | 511 | $1.7K | 2023-06-13 |
| 2026-04-01 | S, sale reported on Form 4 | 7,479 | $125.9K | 2026-04-03 |
| 2026-04-01 | S, sale reported on Form 4 | 500 | $7.9K | 2026-04-03 |
| 2026-04-02 | S, sale reported on Form 4 | 1,780 | $31.3K | 2026-04-03 |
| 2026-04-02 | S, sale reported on Form 4 | 6,200 | $105.5K | 2026-04-03 |
| 2026-04-29 | S, sale reported on Form 4 | 8,458 | $110.7K | 2026-05-01 |
| 2026-04-30 | S, sale reported on Form 4 | 8,457 | $111.9K | 2026-05-01 |
| 2026-05-06 | S, sale reported on Form 4 | 9,219 | $197.0K | 2026-05-07 |
| 2026-05-06 | S, sale reported on Form 4 | 2,700 | $56.1K | 2026-05-07 |
| 2026-05-06 | S, sale reported on Form 4 | 12,347 | $238.1K | 2026-05-07 |
| 2026-05-06 | S, sale reported on Form 4 | 8,900 | $200.9K | 2026-05-07 |
| 2026-05-06 | S, sale reported on Form 4 | 13,834 | $256.6K | 2026-05-07 |
| 2026-05-07 | S, sale reported on Form 4 | 18,606 | $448.8K | 2026-05-11 |
| 2026-08-17 | S, sale reported on Form 4 | 37,945 | $753.3K | 2026-08-19 |
| 2026-08-17 | S, sale reported on Form 4 | 3,749 | $74.8K | 2026-08-19 |
| 2026-08-18 | S, sale reported on Form 4 | 31,031 | $622.3K | 2026-08-19 |
| 2026-09-10 | S, sale reported on Form 4 | 10,185 | $179.5K | 2026-09-11 |
| 2026-09-16 | S, sale reported on Form 4 | 12,394 | $202.4K | 2026-09-18 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1810417) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms